Quarterly report pursuant to Section 13 or 15(d)

Revenues from Contracts and Significant Customers (Company's product revenue) (Details)

v3.22.1
Revenues from Contracts and Significant Customers (Company's product revenue) (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Product revenue, net $ 20,796 $ 10,719
Collaboration revenue 577 800
Revenue - related party 52 68
Other revenue 2,500  
Net revenue 23,925 11,587
Targadox [Member]    
Product revenue, net 2,634 7,199
Ximino [Member]    
Product revenue, net 967 2,100
Exelderm [Member]    
Product revenue, net 704 1,217
Accutane [Member]    
Product revenue, net 4,907 196
Qbrexza [Member]    
Product revenue, net 7,376  
Amzeeq [Member]    
Product revenue, net 3,466  
Zilxi [Member]    
Product revenue, net 741  
Other Branded Revenue [Member]    
Product revenue, net $ 1 $ 7